文献速递围术期管理与 ERAS急腹症与外科感染

行为健康障碍与大手术后新发持续阿片类药物使用的关系

New persistent opioid use among patients with behavioral health disorders following major surgery.
PubMed 文献 · Surgery · 2025-03-07

基于IBM-MarketScan数据库2013至2020年62,585例大手术患者,23.9%术前存在行为健康障碍。术后27.7%使用阿片类药物,其中17.5%出现新发持续使用。行为健康障碍患者新发持续使用率20.3%高于无障碍者16.6%,多变量分析显示其风险增加32%(OR 1.32,95%CI 1.21-1.44)。

要点

  • 行为健康障碍患者大手术后新发持续阿片使用率20.3%,高于无障碍者16.6%。
  • 行为健康障碍与新发持续阿片使用风险增加32%独立相关(OR 1.32,95%CI 1.21-1.44)。
  • 约1/5的行为健康障碍患者大手术后出现新发持续阿片使用。

核心结论

  • 行为健康障碍与大手术后新发持续阿片类药物使用风险升高独立相关。

研究设计与样本

  • 回顾性队列研究,利用IBM-MarketScan数据库纳入2013至2020年接受大手术的62,585例患者。

主要发现

  • 23.9%(14,986例)术前存在行为健康障碍。
  • 术后27.7%(17,315例)使用阿片类药物,其中17.5%(3,034例)出现新发持续使用,中位剂量438 MME(IQR 234-870)。
  • 行为健康障碍组新发持续阿片使用率20.3%,无障碍组16.6%(P<.05)。
  • 行为健康障碍组中位MME 450(IQR 230-960),无障碍组435(IQR 234-845)(P<.05)。
  • 多变量分析显示行为健康障碍与新发持续阿片使用风险增加32%相关(OR 1.32,95%CI 1.21-1.44)。

临床怎么用

  • 大手术术前应筛查行为健康障碍,识别新发持续阿片使用高危患者。
  • 对行为健康障碍患者围术期应加强阿片类药物管理及随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with substance use or mental health disorders may have differential responses to pain after surgery, which may result in higher opioid use. We sought to characterize the association of behavioral health disorders with new persistent opioid use after a major surgical procedure. METHODS: Patients who underwent a major surgical procedure between 2013 and 2020 were identified using the IBM-MarketScan database. Behavioral health disorders included medicinal use disorders, eating/sleeping disorders, or mental health disorders. New persistent opioid use was defined as 2 subsequent opioid refills within 3 and 6 months after surgery among opioid-naïve patients. Multivariable regression was applied to study the association between behavioral health disorders and risk of new persistent opioid use. RESULTS: Among 62,585 patients (coronary artery bypass graft: n = 20,338, 32.5%; pneumonectomy: n = 6,986, 11.2%; abdominal aortic aneurysm repair: n = 1,783, 2.9%; pancreatectomy: n = 1,768, 2.8%; and colectomy: n = 31,710, 50.7%), most were male (n = 37,868, 60.5%) with a median age of 56 (interquartile range: 50-60) years; 23.9% (n = 14,986) had diagnosis of behavioral health disorders before surgery. A total of 27.7% (n = 17,315) of patients had postoperative opioid use, among whom 17.5% (n = 3,034) developed new persistent opioid use with a median dose of 438 (interquartile range: 234-870) morphine milligram equivalents. Patients with behavioral health disorders had a higher incidence of new persistent opioid use (behavioral health disorder: 20.3% vs no behavioral health disorder: 16.6%) with a higher median morphine milligram equivalent dose (behavioral health disorder: 450, interquartile range: 230-960 vs no behavioral health disorder: 435, interquartile range: 234-845) (both P < .05). On multivariable analysis, behavioral health disorders were associated with 32% higher odds of new persistent opioid use (odds ratio: 1.32, 95% confidence interval: 1.21-1.44) compared with no behavioral health disorders. CONCLUSION: Roughly 1 in 5 patients with behavioral health disorders who underwent major surgery developed new persistent opioid use. Patients undergoing surgery often have a high prevalence of behavioral health disorders, which can increase the risk of higher opioid use.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Rashid Z, Macedo AB, Woldesenbet S, et al. New persistent opioid use among patients with behavioral health disorders following major surgery. Surgery. 2025. PMID: 40056725. doi:10.1016/j.surg.2025.109305

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。